Indications for use of amifostine. 1998

R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D004999 Amifostine A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. Ethiofos,Gammaphos,APAETP,Amifostine Anhydrous,Amifostine Disodium Salt,Amifostine Monohydrate,Amifostine Monohydrochloride,Amifostine Trihydrate,Aminopropyl Aminoethylthiophosphate,Aminopropylaminoethylthiophosphate,Aminopropylaminoethylthiophosphoric Acid,Ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), trihydrate,Ethiofos Anhydrous,Ethyol,NSC-296961,S-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid,WR-2721,YM-08310,NSC 296961,NSC296961,WR 2721,WR2721,YM 08310,YM08310
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019610 Cytoprotection The process by which chemical compounds provide protection to cells against harmful agents. Cell Protection,Protection, Cell

Related Publications

R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
December 2002, Seminars in oncology,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
January 2020, Oncology,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
August 1996, Seminars in oncology,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
January 1999, Oncology (Williston Park, N.Y.),
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
November 1984, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
September 1962, Suomen laakarilehti. Finlands lakartidning,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
April 1983, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
October 1999, Cancer biotherapy & radiopharmaceuticals,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
July 1999, Clinical journal of oncology nursing,
R Santolaya-Perrin, and I Castillo-Romera, and T Requena-Caturla
January 1978, Journal of child psychology and psychiatry, and allied disciplines,
Copied contents to your clipboard!